160 related articles for article (PubMed ID: 16363298)
1. [Preoperative use of intravenous iron: a new transfusional therapy].
Bisbe E; Rodríguez C; Ruiz A; Sáez M; Castillo J; Santiveri X
Rev Esp Anestesiol Reanim; 2005 Nov; 52(9):536-40. PubMed ID: 16363298
[TBL] [Abstract][Full Text] [Related]
2. [Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery].
Bisbe E; Sáez M; Nomen N; Castillo J; Santiveri X; Mestre C; Cano X
Rev Esp Anestesiol Reanim; 2003 Oct; 50(8):395-400. PubMed ID: 14601367
[TBL] [Abstract][Full Text] [Related]
3. Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study.
Kim YH; Chung HH; Kang SB; Kim SC; Kim YT
Acta Haematol; 2009; 121(1):37-41. PubMed ID: 19332985
[TBL] [Abstract][Full Text] [Related]
4. Patients with and without rheumatoid arthritis benefit equally from preoperative epoetin-alpha treatment.
Slappendel R; Weber EW; Hémon YJ; Mähler S; Dalén T; Rouwet EF; van Os JJ; Vosmaer A; van der Ark PD
Acta Orthop; 2006 Aug; 77(4):677-83. PubMed ID: 16929448
[TBL] [Abstract][Full Text] [Related]
5. Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study.
Theusinger OM; Leyvraz PF; Schanz U; Seifert B; Spahn DR
Anesthesiology; 2007 Dec; 107(6):923-7. PubMed ID: 18043060
[TBL] [Abstract][Full Text] [Related]
6. Does the preoperative iron status predict transfusion requirement of orthopedic patients?
Fotland SS; Reikvam H; Hervig T; Seghatchian J
Transfus Apher Sci; 2009 Jun; 40(3):213-7. PubMed ID: 19376748
[TBL] [Abstract][Full Text] [Related]
7. Impact of erythropoietin on allogenic blood exposure in orthopedic surgery.
Santoro JE; Eastlack RK; Mirocha JM; Bugbee WD
Am J Orthop (Belle Mead NJ); 2007 Nov; 36(11):600-4. PubMed ID: 18075608
[TBL] [Abstract][Full Text] [Related]
8. Preoperative administration of epoetin alfa to reduce transfusion requirements in elderly patients having primary total hip or knee reconstruction.
Lofthouse RA; Boitano MA; Davis JR; Jinnah RH
J South Orthop Assoc; 2000; 9(3):175-81. PubMed ID: 12135299
[TBL] [Abstract][Full Text] [Related]
9. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study.
Cuenca J; García-Erce JA; Muñoz M; Izuel M; Martínez AA; Herrera A
Transfusion; 2004 Oct; 44(10):1447-52. PubMed ID: 15383017
[TBL] [Abstract][Full Text] [Related]
10. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery.
Cuenca J; García-Erce JA; Martínez F; Pérez-Serrano L; Herrera A; Muñoz M
Transfusion; 2006 Jul; 46(7):1112-9. PubMed ID: 16836557
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia.
Pinsk V; Levy J; Moser A; Yerushalmi B; Kapelushnik J
Isr Med Assoc J; 2008 May; 10(5):335-8. PubMed ID: 18605353
[TBL] [Abstract][Full Text] [Related]
12. An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty.
Gonzalez-Porras JR; Colado E; Conde MP; Lopez T; Nieto MJ; Corral M
Transfus Med; 2009 Feb; 19(1):35-42. PubMed ID: 19302453
[TBL] [Abstract][Full Text] [Related]
13. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.
Straus DJ; Testa MA; Sarokhan BJ; Czuczman MS; Tulpule A; Turner RR; Riggs SA
Cancer; 2006 Oct; 107(8):1909-17. PubMed ID: 16977654
[TBL] [Abstract][Full Text] [Related]
14. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
Pizzarelli F; David S; Sala P; Icardi A; Casani A
Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
[TBL] [Abstract][Full Text] [Related]
15. [Safety and efficacy of total dose intravenous iron infusion in the treatment of iron-deficiency anemia in adult non-pregnant patients].
Reynoso-Gómez E; Salinas-Rojas V; Lazo-Langner A
Rev Invest Clin; 2002; 54(1):12-20. PubMed ID: 11995402
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of once-weekly intravenous epoetin alfa in maintaining hemoglobin levels in hemodialysis patients.
Locatelli F; Villa G; Messa P; Filippini A; Cannella G; De Ferrari G; Naso A; Rossi E; Formica M; Lombardi L; Rotolo U; Conte F
J Nephrol; 2008; 21(3):412-20. PubMed ID: 18587731
[TBL] [Abstract][Full Text] [Related]
17. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery.
Kulier A; Levin J; Moser R; Rumpold-Seitlinger G; Tudor IC; Snyder-Ramos SA; Moehnle P; Mangano DT; ;
Circulation; 2007 Jul; 116(5):471-9. PubMed ID: 17620512
[TBL] [Abstract][Full Text] [Related]
18. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
19. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
20. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):206-16. PubMed ID: 16476841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
